Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A structured evaluation of cryopreservation in generating single-cell transcriptomes from cerebrospinal fluid.
Touil H, Roostaei T, Calini D, Diaconu C, Epstein S, Raposo C, Onomichi K, Thakur KT, Craveiro L, Callegari I, Bryois J, Riley CS, Menon V, Derfuss T, De Jager PL, Malhotra D. Touil H, et al. Among authors: onomichi k. Cell Rep Methods. 2023 Jul 14;3(7):100533. doi: 10.1016/j.crmeth.2023.100533. eCollection 2023 Jul 24. Cell Rep Methods. 2023. PMID: 37533636 Free PMC article.
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, De Jager PL; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Levin SN, et al. Among authors: onomichi kb. Ann Clin Transl Neurol. 2021 Apr;8(4):918-928. doi: 10.1002/acn3.51314. Epub 2021 Feb 22. Ann Clin Transl Neurol. 2021. PMID: 33616290 Free PMC article.
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses.
Epstein SE, Levin S, Onomichi K, Langston C, Yeshokumar A, Fabian M, Sand IK, Klineova S, Lublin F, Dykstra K, Xia Z, De Jager P, Levine L, Farber R, Riley C, Vargas WS. Epstein SE, et al. Among authors: onomichi k. Mult Scler Relat Disord. 2021 Nov;56:103229. doi: 10.1016/j.msard.2021.103229. Epub 2021 Aug 28. Mult Scler Relat Disord. 2021. PMID: 34479112 Free PMC article.
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic.
Levit E, Cohen I, Dahl M, Edwards K, Weinstock-Guttman B, Ishikawa T, Kavak K, Leavitt V, Nelson K, Onomichi K, Bar-Or A, Perrone C, Riley C, Venkatesh S, De Jager PL, Xia Z, Longbrake EE; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Levit E, et al. Among authors: onomichi k. Mult Scler Relat Disord. 2022 Feb;58:103482. doi: 10.1016/j.msard.2021.103482. Epub 2022 Jan 4. Mult Scler Relat Disord. 2022. PMID: 35016114 Free PMC article.
Hypogonadism in men with multiple sclerosis: Prevalence and clinical associations.
Diaconu C, Lee AJ, Onomichi K, De Jager RL, Riley C, Levine L, Vargas W, Shelter K, De Jager PL, Farber RS. Diaconu C, et al. Among authors: onomichi k. Mult Scler Relat Disord. 2022 Mar;59:103508. doi: 10.1016/j.msard.2022.103508. Epub 2022 Jan 10. Mult Scler Relat Disord. 2022. PMID: 35123293
A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement.
Straus Farber R, Walker EL, Diallo F, Onomichi K, Riley C, Zhang L, Zhu W, De Jager PL, Xia Z. Straus Farber R, et al. Among authors: onomichi k. Mult Scler Relat Disord. 2024 Sep;89:105762. doi: 10.1016/j.msard.2024.105762. Epub 2024 Jul 10. Mult Scler Relat Disord. 2024. PMID: 39047340 Free PMC article. Clinical Trial.
Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.
Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC). Cook LJ, et al. Among authors: onomichi kb. Neurol Neuroimmunol Neuroinflamm. 2019 Jun 28;6(5):e583. doi: 10.1212/NXI.0000000000000583. eCollection 2019 Sep. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31355319 Free PMC article.
Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort.
Gholizadeh S, Exuzides A, Lewis KE, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Sinnott J, Cook LJ, Yeaman MR; Guthy-Jackson Charitable Foundation CIRCLES Study Group. Gholizadeh S, et al. J Neurol. 2023 Apr;270(4):2048-2058. doi: 10.1007/s00415-022-11529-6. Epub 2022 Dec 24. J Neurol. 2023. PMID: 36565348 Free PMC article.
14 results